0001387131-18-000786.txt : 20180223 0001387131-18-000786.hdr.sgml : 20180223 20180223180440 ACCESSION NUMBER: 0001387131-18-000786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180221 FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARLO DENNIS J PHD CENTRAL INDEX KEY: 0001038322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36242 FILM NUMBER: 18638043 MAIL ADDRESS: STREET 1: PO BOX 1176 CITY: RANCHO SANTA FE STATE: CA ZIP: 92067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamis Pharmaceuticals Corp CENTRAL INDEX KEY: 0000887247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820429727 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 997-2400 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 310 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CELLEGY PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950615 4 1 carlo-form4_022118.xml OWNERSHIP DOCUMENT X0306 4 2018-02-21 0 0000887247 Adamis Pharmaceuticals Corp ADMP 0001038322 CARLO DENNIS J PHD C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 President & CEO Employee Stock Option (right to buy) 2.83 2018-02-21 4 A 0 166934 0 A 2028-02-21 Common Stock 166934 166934 D Restricted Stock Units 2018-02-21 4 A 0 83467 0 A Common Stock 83467 83467 D The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date. Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock. 1/3 of the RSUs vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period. /s/ Robert O. Hopkins, Power of Attorney for Dennis J. Carlo, Ph.D. 2018-02-23